O9 Solutions to Samsung Bioepis
Providing its own AI-based SCM platform
Provided in SaaS format through Samsung SDS


Onine Solutions Korea announced on the 18th that Samsung Bioepis has adopted its AI-based SCM platform to improve overall management of biopharmaceutical manufacturing and supply.

Samsung Bioepis has solved the challenges of complex supply chain planning and execution through o9 Solutions' AI-based integrated supply chain platform, enabling it to focus solely on biopharmaceutical development, clinical trial management, regulatory registration, manufacturing, and supply. The integrated supply chain platform is provided as a SaaS through Samsung SDS.

O9 Solutions' next-generation, single, integrated SCM platform supports all planning needs, from long-term strategic planning to mid- to long-term and short-term planning. Furthermore, it can be integrated with existing enterprise resource planning (ERP) systems, enhancing financial management efficiency.

“Samsung Bioepis’ adoption of our SCM platform marks o9 Solutions’ first order from a bio company,” said Chakri Gottemukkala, CEO of o9 Solutions. “We will actively support o9 Solutions by providing our solutions for planning and managing the entire pharmaceutical manufacturing and distribution process, reducing costs and increasing productivity.”